Virus role during intraepidemic increase in dengue disease severity

Vector-Borne and Zoonotic Diseases

Volumn 11, Issue 6, 2011, Pages 675-681

  Rodriguez Roche, Rosmari ^a   Sanchez, Lizet ^a   Burgher, Yaima ^b   Rosario, Delfina ^a   Alvarez, Mayling ^a   Kouri, Gustavo ^a   Halstead, Scott B ^c   Gould, Ernie A ^d,e   Guzman, Maria G ^a  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b National Center for Animal and Plant Health CENSA   (Cuba)

^c Pediatric Dengue Vaccine Initiative   (United States)

^d CENTRE FOR ECOLOGY AND HYDROLOGY   (United Kingdom)

^e Aix Marseille University IRD 190 Inserm 1207   (France)

Author keywords

Dengue; Epidemiology; Genetics

Indexed keywords

NONSTRUCTURAL PROTEIN 1; SERINE; THREONINE; VIRUS RNA;

AMINO ACID SUBSTITUTION; ARTICLE; BASIC REPRODUCTION NUMBER; BLOOD SAMPLING; DENGUE; DENGUE VIRUS 2; DISEASE SEVERITY; DISEASE TRANSMISSION; EPIDEMIC; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; IMMUNOFLUORESCENCE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SEROTYPE; VIRAL GENETICS; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS SURVIVAL;

CUBA; DENGUE; DENGUE VIRUS; EPIDEMICS; HUMANS; MUTATION; ODDS RATIO; VIRULENCE; VIRUS REPLICATION;

DENGUE VIRUS TYPE 2;

EID: 79959405281     PISSN: 15303667     EISSN: 15577759     Source Type: Journal    
DOI: 10.1089/vbz.2010.0177     Document Type: Article

References (49)

1. Alcon, S, Talarmin, A, Debruyne, M, Falconar, A, et al. Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol 2002; 40:376-381. (Pubitemid 34130856)
2. Alcon-LePoder, S, Drouet, MT, Roux, P, Frenkiel, MP, et al. The secreted form of dengue virus nonstructural protein NS1 is en-docytosed by hepatocytes and accumulates in late endosomes: implications for viral infectivity. J Virol 2005; 79:11403-11411. (Pubitemid 41170681)
3. Alvarez, M, Rodriguez-Roche, R, Bernardo, L, Morier, L, Guzman, G. Improved dengue virus plaque formation on BHK21 and LLCMK2 cells: evaluation of some factors. Dengue Bull 2005; 29:1-9.
4. Alvarez, M, Rodriguez-Roche, R, Bernardo, L, Vazquez, S, et al. Dengue hemorrhagic fever caused by sequential dengue 1-3 virus infections over a long time interval: Havana epidemic, 2001-2002. Am J Trop Med Hyg 2006; 75:1113-1117. (Pubitemid 351627493)
5. Bennett, SN, Holmes, EC, Chirivella, M, Rodriguez, DM, et al. Selection-driven evolution of emergent dengue virus. Mol Biol Evol 2003; 20:1650-1658. (Pubitemid 41070827)
6. Betts, MJ, Russell, RB. Amino acid properties and consequences of substitutions. In: Barnes, MR, Gray, IC, eds. Bioinformatics for Geneticists. Wiley, New Jersey: 2003; 289-316.
7. Blok, J, Gibbs, AJ, McWilliam, SM, Vitarana, UT. NS 1 gene sequences from eight dengue-2 viruses and their evolutionary relationships with other dengue-2 viruses. Arch Virol 1991; 118:209-223.
8. Chareonsirisuthigul, T, Kalayanarooj, S, Ubol, S. Dengue virus (DENV) antibody-dependent enhancement of infection upre-gulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. J Gen Virol 2007; 88(Pt 2): 365-375. (Pubitemid 46210873)
9. Charnsilpa, W, Takhampunya, R, Endy, TP, Mammen, MP, Jr., et al. Nitric oxide radical suppresses replication of wild-type dengue 2 viruses in vitro. J Med Virol 2005; 77:89-95. (Pubitemid 41076482)
10. dos Santos, CN, Rocha, CF, Cordeiro, M, Fragoso, SP, et al. Genome analysis of dengue type-1 virus isolated between 1990 and 2001 in Brazil reveals a remarkable conservation of the structural proteins but amino acid differences in the non-structural proteins. Virus Res 2002; 90:197-205. (Pubitemid 35375835)
11. Gritsun, TS, Liapustin, VN, Shatalov, AG, Lashkevich, VA. Multiple forms of the NS1 protein as the main component of the nonvirion ("soluble") antigen of the tick-borne encephalitis virus. Vopr Virusol 1990; 35:471-474.
12. Gubler, DJ, Reed, D, Rosen, L, Hitchcock, JR, Jr. Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga. Am J Trop Med Hyg 1978; 27:581-589. (Pubitemid 8367657)
13. Guzman, MG, Alvarez, M, Rodriguez, R, Rosario, D, et al. Fatal dengue hemorrhagic fever in Cuba, 1997. Int J Infect Dis 1999; 3:130-135. (Pubitemid 29385744)
14. Guzman, MG, Deubel, V, Pelegrino, JL, Rosario, D, et al. Partial nucleotide and amino acid sequences of the envelope and the envelope/ nonstructural protein-1 gene junction of four dengue-2 virus strains isolated during the 1981 Cuban epidemic. Am J Trop Med Hyg 1995; 52:241-246.
15. Guzman, MG, Kouri, G. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol 2003; 27:1-13. (Pubitemid 36513584)
16. Guzman, MG, Kouri, G, Bravo, J, Soler, M, Martinez, E. Sequential infection as risk factor for dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) during the 1981 dengue hemorrhagic Cuban epidemic. Mem Inst Oswaldo Cruz 1991; 86:367.
17. Guzman, MG, Kouri, GP, Bravo, J, Soler, M, et al. Dengue hemorrhagic fever in Cuba, 1981: a retrospective ser-oepidemiologic study. Am J Trop Med Hyg 1990; 42:179-184. (Pubitemid 20093452)
18. Guzman, MG, Kouri, G, Halstead, SB. Do escape mutants explain rapid increases in dengue case-fatality rates within epidemics? Lancet 2000a; 355:1902-1903. (Pubitemid 30311889)
19. Guzman, MG, Kouri, G, Valdes, L, Bravo, J, et al. Epidemiologic studies on Dengue in Santiago de Cuba, 1997. Am J Epidemiol 2000b; 152:793-799.
20. Guzman, MG, Kouri, G, Valdes, L, Bravo, J, et al. Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. Rev Panam Salud Publica 2002; 11:223-227. (Pubitemid 34555771)
21. Halstead, S. Antibody-Dependent Enhancement of Infection: A Mechanism for Indirect Virus Entry into Cells. In: Wimmer E, ed. Cellular Receptors for Animal Viruses. Cold Spring Harbor Laboratory Press, New York: 1994; 493-515.
22. Halstead, SB. Dengue. Lancet 2007; 370:1644-1652. (Pubitemid 350052290)
23. Halstead, SB, Nimmannitya, S, Cohen, SN. Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med 1970; 42:311-328.
24. Henchal, EA, McCown, JM, Burke, DS, Seguin, MC, Brandt, WE. Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies. Am J Trop Med Hyg 1985; 34:162-169. (Pubitemid 15174332)
25. Klungthong, C, Zhang, C, Mammen, MP, Jr., Ubol, S, Holmes, EC. The molecular epidemiology of dengue virus serotype 4 in Bangkok, Thailand. Virology 2004; 329:168-179. (Pubitemid 39346038)
26. Kochel, TJ, Watts, DM, Gozalo, AS, Ewing, DF, et al. Crossserotype neutralization of Dengue virus in Aotus nancymae monkeys. J Infect Dis 2005; 191:1000-1004. (Pubitemid 40349818)
27. Kochel, TJ, Watts, DM, Halstead, SB, Hayes, CG, et al. Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever. Lancet 2002; 360:310-312. (Pubitemid 34874726)
28. Kouri, G, Guzman, MG, Valdes, L, Carbonel, I, et al. Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba. Emerg Infect Dis 1998; 4:89-92. (Pubitemid 28347419)
29. Kouri, GP, Guzman, MG, Bravo, JR, Triana, C. Dengue haemor-rhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981. Bull World Health Organ 1989; 67:375-380. (Pubitemid 19248539)
30. Kurane, I. Dengue hemorrhagic fever with special emphasis on immunopathogenesis. Comp Immunol Microbiol Infect Dis 2007; 30:329-340. (Pubitemid 47450087)
31. Libraty, DH, Young, PR, Pickering, D, Endy, TP, et al. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis 2002; 186:1165-1168. (Pubitemid 35177121)
32. Marques, CA, Forattini, OP, Massad, E. The basic reproduction number for dengue fever in Sao Paulo state, Brazil: 1990-1991 epidemic. Trans R Soc Trop Med Hyg 1994; 88:58-59.
33. Morens, DM, Halstead, SB, Repik, PM, Putvatana, R, Raybourne, N. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J Clin Microbiol 1985; 22:250-254. (Pubitemid 15006964)
34. PAHO. Dengue and Dengue Hemorrhagic Fever in the Americas: Guidelines for Prevention and Control. Scientific publication no. 548. Washington: PAHO, 1994.
35. Pelaez, O, Guzman, MG, Kouri, G, Perez, R, et al. Dengue 3 epidemic, Havana, 2001. Emerg Infect Dis 2004; 10:719-722. (Pubitemid 38420309)
36. Rice, CM. Flaviviridae: the viruses and their replication. In: Fields, BM, ed. Virology. Philadelphia-New York: Lippincott-Raven, 1996:931-960.
37. Rico-Hesse, R. Dengue virus evolution and virulence models. Clin Infect Dis 2007; 44:1462-1466. (Pubitemid 46801591)
38. Rico-Hesse, R. Microevolution and virulence of dengue viruses. Adv Virus Res 2003; 59:315-341. (Pubitemid 137639369)
39. Rico-Hesse, R, Harrison, LM, Salas, RA, Tovar, D, et al. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 1997; 230:244-251. (Pubitemid 27211855)
40. Rigau-Perez, JG, Vorndam, AV, Clark, GG. The dengue and dengue hemorrhagic fever epidemic in Puerto Rico, 1994-1995. Am J Trop Med Hyg 2001; 64:67-74. (Pubitemid 32550101)
41. Rodriguez-Roche, R, Alvarez, M, Gritsun, T, Halstead, S, et al. Virus evolution during a severe dengue epidemic in Cuba, 1997. Virology 2005a; 334:154-159. (Pubitemid 40386950)
42. Rodriguez-Roche, R, Alvarez, M, Gritsun, T, Rosario, D, et al. Dengue virus type 2 in Cuba, 1997: conservation of E gene sequence in isolates obtained at different times during the epidemic. Arch Virol 2005b; 150:415-425. (Pubitemid 40383677)
43. Rodriguez-Roche, R, Alvarez, M, Guzman, MG, Morier, L, Kouri, G. Comparison of rapid centrifugation assay with conventional tissue culture method for isolation of dengue 2 virus in C6/36-HT cells. J Clin Microbiol 2000; 38:3508-3510.
44. Rodriguez-Roche, R, Alvarez, M, Holmes, EC, Bernardo, L, et al. Dengue virus type 3, Cuba, 2000-2002. Emerg Infect Dis 2005c; 11:773-774. (Pubitemid 40586412)
45. Rosen, L. The Emperor's New Clothes revisited, or reflections on the pathogenesis of dengue hemorrhagic fever. Am J Trop Med Hyg 1977; 26:337-343. (Pubitemid 8136731)
46. Ubol, S, Chareonsirisuthigul, T, Kasisith, J, Klungthong, C. Clinical isolates of dengue virus with distinctive susceptibility to nitric oxide radical induce differential gene responses in THP-1 cells. Virology 2008; 376:290-296.
47. Valdes, L, Guzman, MG, Kouri, G, Delgado, J, et al. [Epidemiology of dengue and hemorrhagic dengue in Santiago, Cuba 1997]. Rev Panam Salud Publica 1999; 6:16-25. (Pubitemid 29364519)
48. Watts, DM, Porter, KR, Putvatana, P, Vasquez, B, et al. Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever. Lancet 1999; 354:1431-1434. (Pubitemid 29494755)
49. Young, PR, Hilditch, PA, Bletchly, C, Halloran, W. An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J Clin Microbiol 2000; 38:1053-1057. (Pubitemid 30140558)